V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010184 | 190006304 | 1.61 | 88 | null | 2019-03-14 | 2019-03-14 | Lomustine | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 101784800 |
| 190010190 | 190006305 | 1.61 | 24.9 | null | null | 2018-01-01 | EW EuroEwing 2012 Arm B VC | null | null | EW EUROEWING 2012 ARM B VC | 100306730 |
| 190010207 | 190006306 | 1.59 | null | Curative (C) | 2018-05-28 | 2018-05-29 | null | N | Y | DOXORUBICIN + HD MTX | 101468612 |
| 190010208 | 190006307 | 1.32 | 57.9 | null | 2017-12-29 | 2018-06-28 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100558816 |
| 190010209 | 190006308 | 1.65 | 65.8 | Palliative (P) | 2018-03-28 | 2019-07-15 | DOXORUBICIN | 02 | null | DOXORUBICIN | 101521478 |
| 190010215 | 190006309 | 1.45 | 66 | Palliative (P) | 2019-12-30 | 2020-01-21 | CAPECITABINE + CARBOPLATIN + Cetuximab | 01 | N | MAP | 100957220 |
| 190010216 | 190006310 | 1.58 | 74 | null | 2018-10-06 | 2018-10-10 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101755258 |
| 190010230 | 190006311 | 1.71 | 57 | Palliative (P) | null | 2019-09-01 | CISPLATIN + GEMCITABINE | 02 | null | OST MIFAMURTIDE | 101443810 |
| 190010231 | 190006312 | null | 77 | null | 2020-11-06 | 2020-11-07 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100343325 |
| 190010232 | 190006313 | 0 | 29 | null | null | 2020-12-24 | ETOPOSIDE + IFOSFAMIDE | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100717091 |
| 190010245 | 190006315 | 1.5 | 97.05 | null | 2019-02-04 | 2019-03-06 | Ifosfamide | 01 | N | DOXORUBICIN + METHOTREXATE | 101194627 |
| 190010254 | 190006316 | 1.6 | 71.15 | Palliative (P) | null | 2016-12-03 | ETOPOSIDE | 02 | null | ETOPOSIDE | 101655316 |
| 190010258 | 190006317 | 1.72 | 10.4 | Adjuvant (A) | 2015-05-05 | 2016-10-13 | null | 01 | N | TRABECTEDIN | 100204570 |
| 190010259 | 190006318 | 0 | 56.9 | Palliative (P) | 2018-02-10 | 2018-09-19 | MAP | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101864734 |
| 190010285 | 190006319 | 1.68 | 36.8 | 03 | 2016-05-02 | 2016-05-26 | Cisplatin + Radiotherapy | 02 | N | EW EUROEWING 2012 ARM A VAI | 100136710 |
| 190010287 | 190006320 | 1.59 | 58.4 | null | null | 2018-10-06 | METHOTREXATE | 01 | null | METHOTREXATE | 100344296 |
| 190010289 | 190006321 | 1.8 | 96.5 | null | 2019-04-03 | 2019-09-11 | NB REL CCLG GUIDELINES CYCLO-IMATINIB + TOPOTECAN | 02 | null | CAV | 100576507 |
| 190010293 | 190006322 | 1.52 | 35 | Neo-adjuvant (N) | 2018-08-30 | 2018-09-06 | OST Mifamurtide | N | N | TRIAL | 101826975 |
| 190010295 | 190006323 | 1.88 | 79.8 | 03 | 2019-11-14 | 2020-06-06 | TEMOZOLOMIDE | 02 | N | VIDE | 101658414 |
| 190010298 | 190006324 | 1.65 | 76.8 | null | 2017-12-26 | 2018-01-16 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101616146 |
| 190010303 | 190006325 | 1.56 | 104.3 | Palliative (P) | null | 2016-03-19 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 100662844 |
| 190010305 | 190006326 | 1.74 | 57.75 | null | 2018-01-04 | 2018-01-05 | null | 02 | N | EURAMOS TRIAL | 100015398 |
| 190010308 | 190006327 | 1.79 | 76.3 | Neo-adjuvant (N) | 2018-01-29 | 2018-01-29 | DHAP | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 100028419 |
| 190010329 | 190006328 | 1.84 | 57.75 | Adjuvant (A) | 2017-08-30 | 2017-08-31 | Rituximab | N | N | CISPLATIN + DOXORUBICIN | 100820212 |
| 190010345 | 190006329 | 0 | 24.9 | Palliative (P) | 2018-11-13 | 2019-05-18 | OST Euramos 1 Closed Trial - M | 02 | N | ETOPOSIDE | 100095564 |
| 190010347 | 190006330 | 1.6 | 64.6 | Curative (C) | 2017-01-27 | 2017-01-27 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 100457965 |
| 190010348 | 190006331 | 1.63 | 63.8 | Palliative (P) | 2019-05-24 | 2019-05-28 | Etoposide + Ifosfamide (5 days) | null | null | ETOPOSIDE + IFOSFAMIDE | 100421315 |
| 190010353 | 190006332 | 1.7 | 82.8 | Adjuvant (A) | 2019-02-23 | 2019-05-18 | ETOPOSIDE + IFOSFAMIDE + MESNA | 01 | N | ETOPOSIDE + IFOSFAMIDE | 100566701 |
| 190010357 | 190006333 | 1.66 | null | Palliative (P) | 2017-04-26 | 2017-05-18 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101238553 |
| 190010358 | 190006334 | 1.7 | 111 | Palliative (P) | 2020-04-16 | 2020-05-02 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100958431 |
| 190010360 | 190006335 | 0 | 15 | 03 | null | 2019-10-15 | null | 02 | N | METHOTREXATE HIGH DOSE | 100086863 |
| 190010363 | 190006336 | null | 65.5 | Neo-adjuvant (N) | 2018-07-01 | 2018-07-01 | EURAMOS TRIAL | 02 | null | EW EUROEWING 2012 ARM A VAI | 101818627 |
| 190010364 | 190006337 | 0 | 63.2 | Palliative (P) | 2021-04-07 | 2021-04-08 | Paclitaxel 7 day | 02 | null | NOT MATCHED | 100647797 |
| 190010375 | 190006338 | 1.9 | null | null | 2020-12-12 | 2021-07-07 | Dox + HD Mtx (post PAM) | N | N | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100484423 |
| 190010378 | 190006339 | 0 | 28.8 | null | 2021-01-09 | 2021-05-21 | EW EuroEwing 2012 Arm B VC | N | N | EW EUROEWING 2012 ARM B VC | 101604181 |
| 190010381 | 190006340 | 1.7 | 77.9 | Palliative (P) | 2019-09-14 | 2020-02-23 | DOXORUBICIN | N | N | DOXORUBICIN | 101291508 |
| 190010382 | 190006341 | null | 66.6 | Adjuvant (A) | 2020-05-30 | 2020-11-11 | OST Rel Ifosfamide Etoposide | 02 | N | OST MIFAMURTIDE | 100271314 |
| 190010385 | 190006342 | 0 | 24.4 | Adjuvant (A) | 2018-05-28 | 2018-10-06 | EW EuroEwing 2012 Arm B VC | 01 | N | EW EUROEWING 2012 ARM B VC | 100094246 |
| 190010413 | 190006343 | null | 84.2 | Adjuvant (A) | 2018-05-14 | 2018-05-31 | Cisplatin + Radiotherapy | 02 | N | CARBOPLATIN + PACLITAXEL | 101790227 |
| 190010417 | 190006345 | 1.78 | 47.7 | null | 2017-11-06 | 2018-12-27 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100684600 |
| 190010425 | 190006346 | 0 | 64 | null | 2017-02-13 | 2017-06-07 | EURAMOS TRIAL | 01 | N | FLUOROURACIL + OXALIPLATIN | 100927778 |
| 190010450 | 190006347 | 1.6 | 102.2 | Curative (C) | 2019-03-23 | 2019-03-23 | STS Non-Rhabdo EpSSG 2005 IVA | 01 | N | METHOTREXATE HIGH DOSE | 101280855 |
| 190010453 | 190006348 | 1.74 | 91.4 | Curative (C) | 2020-01-28 | 2020-02-11 | DOXORUBICIN | N | N | DOXORUBICIN | 100633818 |
| 190010454 | 190006349 | 1.93 | 75.3 | Curative (C) | 2018-11-15 | 2018-11-18 | DOXORUBICIN + METHOTREXATE | 02 | N | TRIAL | 101277987 |
| 190010455 | 190006350 | 1.81 | 75.8 | null | 2017-12-07 | 2018-01-04 | Cisplatin + Radiotherapy | 02 | N | CAV | 100331847 |
| 190010459 | 190006351 | 0 | 53 | Curative (C) | 2016-08-27 | 2017-02-22 | EW EuroEwing 2012 Arm B IE | 02 | Y | EW EUROEWING 2012 ARM B IE | 101317669 |
| 190010462 | 190006352 | 0 | 84 | Palliative (P) | 2016-12-19 | 2016-12-20 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101564620 |
| 190010465 | 190006353 | 1.81 | 18.9 | Neo-adjuvant (N) | null | 2021-02-04 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100989131 |
| 190010472 | 190006354 | 1.6 | 76 | Curative (C) | 2019-01-15 | 2019-01-15 | Carboplatin + Etoposide IV 3 day | 02 | N | TOPOTECAN | 101104561 |
| 190010473 | 190006355 | 0 | 42.8 | Curative (C) | 2020-07-24 | 2020-08-12 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 100010762 |